Metagenomi

Metagenomi uses AI to discover novel gene editing systems from metagenomic data for therapeutic applications beyond traditional CRISPR-Cas9.
Domain
Healthcare
Status
IPO’d/​Acquired
IPO Date
2024
Stage of Initial Investment
Series A
Initial Investment Year
2021